1 Study Coverage
1.1 Diphtheria, Pertussis, and Tetanus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 DTaP
1.2.3 Td
1.2.4 Tdap
1.3 Market by Application
1.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Vaccination Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production
2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity (2017-2028)
2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region: 2017 VS 2021 VS 2028
2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region
2.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historic Production by Region (2017-2022)
2.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales in Volume & Value Estimates and Forecasts
3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Estimates and Forecasts 2017-2028
3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Estimates and Forecasts 2017-2028
3.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
3.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022)
3.4.2 Global Sales Diphtheria, Pertussis, and Tetanus Vaccine by Region (2023-2028)
3.5 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region
3.5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022)
3.5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Manufacturers
4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers
4.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers (2017-2022)
4.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine in 2021
4.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers
4.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers (2017-2022)
4.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2021
4.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type
5.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Sales by Type (2017-2022)
5.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Sales by Type (2023-2028)
5.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
5.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type
5.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Revenue by Type (2017-2022)
5.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Revenue by Type (2023-2028)
5.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
5.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type
5.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2022)
5.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application
6.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Sales by Application (2017-2022)
6.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Sales by Application (2023-2028)
6.1.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application
6.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Historical Revenue by Application (2017-2022)
6.2.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Forecasted Revenue by Application (2023-2028)
6.2.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
6.3 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application
6.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2022)
6.3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Application (2023-2028)
7 North America
7.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
7.1.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
7.1.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
7.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
7.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
7.2.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
7.3 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
7.3.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
7.3.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
8.1.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
8.1.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
8.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
8.2.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
8.2.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
8.3 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
8.3.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
8.3.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
9.1.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
9.1.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
9.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
9.2.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
9.2.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
9.3 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region
9.3.1 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2028)
9.3.2 Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
10.1.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
10.1.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
10.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
10.2.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
10.2.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
10.3 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
10.3.1 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
10.3.2 Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Type
11.1.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2028)
11.1.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2028)
11.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Market Size by Application
11.2.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2028)
11.2.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2028)
11.3 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country
11.3.1 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2028)
11.3.2 Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Overview
12.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Johnson & Johnson Recent Developments
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Corporation Information
12.2.2 GlaxoSmithKline Overview
12.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 GlaxoSmithKline Recent Developments
12.3 Sanofi
12.3.1 Sanofi Corporation Information
12.3.2 Sanofi Overview
12.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Sanofi Recent Developments
12.4 Lanzhou Institute of Biological
12.4.1 Lanzhou Institute of Biological Corporation Information
12.4.2 Lanzhou Institute of Biological Overview
12.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Lanzhou Institute of Biological Recent Developments
12.5 Merck
12.5.1 Merck Corporation Information
12.5.2 Merck Overview
12.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Merck Recent Developments
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Overview
12.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Novartis Recent Developments
12.7 AstraZeneca
12.7.1 AstraZeneca Corporation Information
12.7.2 AstraZeneca Overview
12.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 AstraZeneca Recent Developments
12.8 Emergent
12.8.1 Emergent Corporation Information
12.8.2 Emergent Overview
12.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Emergent Recent Developments
12.9 Astellas
12.9.1 Astellas Corporation Information
12.9.2 Astellas Overview
12.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Astellas Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Chain Analysis
13.2 Diphtheria, Pertussis, and Tetanus Vaccine Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Diphtheria, Pertussis, and Tetanus Vaccine Production Mode & Process
13.4 Diphtheria, Pertussis, and Tetanus Vaccine Sales and Marketing
13.4.1 Diphtheria, Pertussis, and Tetanus Vaccine Sales Channels
13.4.2 Diphtheria, Pertussis, and Tetanus Vaccine Distributors
13.5 Diphtheria, Pertussis, and Tetanus Vaccine Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Diphtheria, Pertussis, and Tetanus Vaccine Industry Trends
14.2 Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
14.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
14.4 Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
15 Key Finding in The Global Diphtheria, Pertussis, and Tetanus Vaccine Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of DTaP
Table 3. Major Manufacturers of Td
Table 4. Major Manufacturers of Tdap
Table 5. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region: 2017 VS 2021 VS 2028 (K MT)
Table 7. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region (2017-2022) & (K MT)
Table 8. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2017-2022)
Table 9. Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Region (2023-2028) & (K MT)
Table 10. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2023-2028)
Table 11. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022) & (K MT)
Table 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2017-2022)
Table 14. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2023-2028) & (K MT)
Table 15. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2023-2028)
Table 16. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2017-2022)
Table 18. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region (2023-2028)
Table 20. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Capacity by Manufacturers (2017-2022) & (K MT)
Table 21. Global Diphtheria, Pertussis, and Tetanus Vaccine Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Manufacturers (2017-2022) & (K MT)
Table 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Manufacturers (2017-2022)
Table 26. Diphtheria, Pertussis, and Tetanus Vaccine Price by Manufacturers 2017-2022 (USD/MT)
Table 27. Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Diphtheria, Pertussis, and Tetanus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria, Pertussis, and Tetanus Vaccine as of 2021)
Table 29. Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Diphtheria, Pertussis, and Tetanus Vaccine Product Offered
Table 31. Date of Manufacturers Enter into Diphtheria, Pertussis, and Tetanus Vaccine Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 34. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 35. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Type (2017-2022)
Table 36. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Type (2023-2028)
Table 37. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Type (2017-2022)
Table 40. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Type (2023-2028)
Table 41. Diphtheria, Pertussis, and Tetanus Vaccine Price by Type (2017-2022) & (USD/MT)
Table 42. Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Type (2023-2028) & (USD/MT)
Table 43. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 44. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 45. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Application (2017-2022)
Table 46. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Application (2023-2028)
Table 47. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Application (2017-2022)
Table 50. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Application (2023-2028)
Table 51. Diphtheria, Pertussis, and Tetanus Vaccine Price by Application (2017-2022) & (USD/MT)
Table 52. Global Diphtheria, Pertussis, and Tetanus Vaccine Price Forecast by Application (2023-2028) & (USD/MT)
Table 53. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 54. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 55. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 58. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 59. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K MT)
Table 62. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K MT)
Table 63. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 66. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 67. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 70. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 71. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K MT)
Table 74. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K MT)
Table 75. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 78. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 79. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 82. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 83. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2017-2022) & (K MT)
Table 86. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales by Region (2023-2028) & (K MT)
Table 87. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 90. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 91. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 94. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 95. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K MT)
Table 98. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K MT)
Table 99. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2017-2022) & (K MT)
Table 102. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Type (2023-2028) & (K MT)
Table 103. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2017-2022) & (K MT)
Table 106. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Application (2023-2028) & (K MT)
Table 107. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2017-2022) & (K MT)
Table 110. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales by Country (2023-2028) & (K MT)
Table 111. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 113. Johnson & Johnson Corporation Information
Table 114. Johnson & Johnson Description and Major Businesses
Table 115. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 116. Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Johnson & Johnson Recent Development
Table 118. GlaxoSmithKline Corporation Information
Table 119. GlaxoSmithKline Description and Major Businesses
Table 120. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 121. GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. GlaxoSmithKline Recent Development
Table 123. Sanofi Corporation Information
Table 124. Sanofi Description and Major Businesses
Table 125. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 126. Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Sanofi Recent Development
Table 128. Lanzhou Institute of Biological Corporation Information
Table 129. Lanzhou Institute of Biological Description and Major Businesses
Table 130. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 131. Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Lanzhou Institute of Biological Recent Development
Table 133. Merck Corporation Information
Table 134. Merck Description and Major Businesses
Table 135. Merck Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 136. Merck Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Merck Recent Development
Table 138. Novartis Corporation Information
Table 139. Novartis Description and Major Businesses
Table 140. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 141. Novartis Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Novartis Recent Development
Table 143. AstraZeneca Corporation Information
Table 144. AstraZeneca Description and Major Businesses
Table 145. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 146. AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. AstraZeneca Recent Development
Table 148. Emergent Corporation Information
Table 149. Emergent Description and Major Businesses
Table 150. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 151. Emergent Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Emergent Recent Development
Table 153. Astellas Corporation Information
Table 154. Astellas Description and Major Businesses
Table 155. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 156. Astellas Diphtheria, Pertussis, and Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Astellas Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Diphtheria, Pertussis, and Tetanus Vaccine Distributors List
Table 161. Diphtheria, Pertussis, and Tetanus Vaccine Customers List
Table 162. Diphtheria, Pertussis, and Tetanus Vaccine Market Trends
Table 163. Diphtheria, Pertussis, and Tetanus Vaccine Market Drivers
Table 164. Diphtheria, Pertussis, and Tetanus Vaccine Market Challenges
Table 165. Diphtheria, Pertussis, and Tetanus Vaccine Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Diphtheria, Pertussis, and Tetanus Vaccine Product Picture
Figure 2. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Type in 2021 & 2028
Figure 3. DTaP Product Picture
Figure 4. Td Product Picture
Figure 5. Tdap Product Picture
Figure 6. Global Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Vaccination Centers
Figure 10. Diphtheria, Pertussis, and Tetanus Vaccine Report Years Considered
Figure 11. Global Diphtheria, Pertussis, and Tetanus Vaccine Capacity, Production and Utilization (2017-2028) & (K MT)
Figure 12. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2017-2022)
Figure 14. Global Diphtheria, Pertussis, and Tetanus Vaccine Production Market Share by Region (2023-2028)
Figure 15. Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate in North America (2017-2028) & (K MT)
Figure 16. Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate in Europe (2017-2028) & (K MT)
Figure 17. Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate in China (2017-2028) & (K MT)
Figure 18. Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate in Japan (2017-2028) & (K MT)
Figure 19. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales 2017-2028 (K MT)
Figure 20. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue 2017-2028 (US$ Million)
Figure 22. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2017-2022)
Figure 24. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Region (2023-2028)
Figure 25. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales YoY (2017-2028) & (K MT)
Figure 26. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales YoY (2017-2028) & (K MT)
Figure 28. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales YoY (2017-2028) & (K MT)
Figure 30. Asia-Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales YoY (2017-2028) & (K MT)
Figure 32. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales YoY (2017-2028) & (K MT)
Figure 34. Middle East & Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Diphtheria, Pertussis, and Tetanus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Diphtheria, Pertussis, and Tetanus Vaccine in the World: Market Share by Diphtheria, Pertussis, and Tetanus Vaccine Revenue in 2021
Figure 37. Diphtheria, Pertussis, and Tetanus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 39. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
Figure 40. Global Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 41. Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
Figure 42. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 43. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
Figure 44. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 45. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
Figure 46. North America Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Country (2017-2028)
Figure 47. North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Country (2017-2028)
Figure 48. U.S. Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 51. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
Figure 52. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
Figure 54. Europe Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Country (2017-2028)
Figure 55. Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Country (2017-2028)
Figure 56. Germany Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 57. France Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Region (2017-2028)
Figure 67. China Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 70. India Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 72. Taiwan Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 76. Philippines Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 78. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
Figure 79. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 80. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Country (2017-2028)
Figure 82. Latin America Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Country (2017-2028)
Figure 83. Mexico Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Brazil Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 85. Argentina Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Diphtheria, Pertussis, and Tetanus Vaccine Revenue Share by Country (2017-2028)
Figure 92. Turkey Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 94. U.A.E Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 95. Diphtheria, Pertussis, and Tetanus Vaccine Value Chain
Figure 96. Diphtheria, Pertussis, and Tetanus Vaccine Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed
